KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Short-term Investments (2018 - 2025)

BioNTech SE's Short-term Investments history spans 8 years, with the latest figure at $8.4 billion for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 11.73% to $8.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.4 billion, a 11.73% increase, with the full-year FY2025 number at $8.1 billion, up 8.44% from a year prior.
  • Short-term Investments hit $8.4 billion in Q4 2025 for BioNTech SE, up from $5.2 billion in the prior quarter.
  • Over the last five years, Short-term Investments for BNTX hit a ceiling of $8.4 billion in Q4 2025 and a floor of $603118.1 in Q1 2021.
  • Historically, Short-term Investments has averaged $3.5 billion across 5 years, with a median of $3.3 billion in 2023.
  • Biggest five-year swings in Short-term Investments: crashed 55.73% in 2022 and later soared 27727.46% in 2023.
  • Tracing BNTX's Short-term Investments over 5 years: stood at $436.5 million in 2021, then crashed by 55.73% to $193.2 million in 2022, then soared by 2620.16% to $5.3 billion in 2023, then skyrocketed by 42.75% to $7.5 billion in 2024, then rose by 11.73% to $8.4 billion in 2025.
  • Business Quant data shows Short-term Investments for BNTX at $8.4 billion in Q4 2025, $5.2 billion in Q3 2025, and $4.3 billion in Q2 2025.